New subsidiary will further the Company’s research into treating COVID-related heart muscle injury. A patent has been filed for a...
DENVER, CO, March 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”)...
The two neurology device companies will join forces in a clinical trial seeking to reduce the symptoms of autism in...
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology,...
BrightInsight Accelerates Time to Market for the AstraZeneca AMAZE Disease Management Platform Within a Regulatory-Compliant Environment BrightInsight and AstraZeneca Collaborate...
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR) (“Better Choice” or the “Company”), an animal...
San Diego, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical...
Phase 2 AFFINITY Trial of Atrasentan for Patients with Glomerular Diseases Also on Track to Begin Enrollment in the First...
SAFEbody technology enables precision masking of antibodies for enhanced safetySAN FRANCISCO and SUZHOU, China, March 16, 2021 (GLOBE NEWSWIRE) --...
VANCOUVER, B.C. / BOSTON, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF)...
Reported top-line results from Phase 2 SIGNAL study that indicates potential cognitive benefit of pepinemab in neurodegenerative disease. New Alzheimer’s...
The Leader in Telehealth Broadens Oral Care Retail Presence with Walmart Partnership SmileDirectClub Electric Toothbrush SmileDirectClub's innovative oral care products...
AUSTIN, Texas, March 16, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Dr....
Effectiveness and Utility of SRT-100™ Demonstrated in the Companion-Animal Market Best-in-class localization features of SRT-100 enable new radiation therapy options...
New Phase IIb trial called TACTI-003, to evaluate eftilagimod alpha in combination with MSD’s KEYTRUDA® (pembrolizumab) in 1st line head...
Accelerating Scale by Expanding Geographical Operating Footprint with New Location in Florida and New HampshireCINCINNATI, March 16, 2021 (GLOBE NEWSWIRE)...
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments...
Four abstracts accepted as poster presentations for the Endocrine Society’s Annual MeetingLYON, France and NEWTON, Mass., March 16, 2021 (GLOBE...
-Post Hoc analysis published in The Journal of Emergency Medicine demonstrates patients with moderate to severe CABP can be managed...
Topline Results Expected in the Second Quarter of 2021SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO)...